6.85
price down icon1.01%   -0.14
 
loading

Cybin Inc Aktie (CYBN) Neueste Nachrichten

pulisher
Apr 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Apr 27, 2025
pulisher
Apr 23, 2025

Cybin advances Phase 3 trial for depression treatment By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Announces Additional Strategic Clinical Site Partnerships - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin (CYBN) Expands Strategic Partnerships for Phase 3 MDD Program | CYBN Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin advances Phase 3 trial for depression treatment - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Says Second Phase 3 Study Embrace Expected To Begin Mid-2025 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

CYBNCybin Inc Latest Stock News & Market Updates - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003 - The Joplin Globe

Apr 23, 2025
pulisher
Apr 22, 2025

(CYBN) Trading Report - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 21, 2025

Cybin (CYBN) Partners with Osmind for Psychedelic Therapy Launch - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Psychedelic drug developer Cybin partners with Osmind (CYBN:NYSE) - Seeking Alpha

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - 01net

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners With Osmind to Support Psychiatry Program Pipeline - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs | CYBN Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Cybin's Game-Changing Mental Health Partnership: 800+ Clinics to Deploy Novel Depression and Anxiety Treatments - Stock Titan

Apr 21, 2025
pulisher
Apr 05, 2025

Where are the Opportunities in (CYBN) - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 04, 2025

Filament Health secures investment to remedy concerning financial position - Mugglehead Magazine

Apr 04, 2025
pulisher
Apr 03, 2025

4 Psychedelic Stocks to Buy Now - The Motley Fool

Apr 03, 2025
pulisher
Mar 30, 2025

CYBN Stock Forecast: Projections From 2025 To 2040 - Exla Resources

Mar 30, 2025
pulisher
Mar 28, 2025

Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th - Business Wire

Mar 28, 2025
pulisher
Mar 20, 2025

Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - MSN

Mar 20, 2025
pulisher
Mar 16, 2025

(CYBN) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 12, 2025

Cybin initiated with a Buy at Guggenheim - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks

Mar 11, 2025
pulisher
Mar 07, 2025

Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 04, 2025

Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq

Mar 04, 2025
pulisher
Mar 01, 2025

Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 23, 2025

Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN

Feb 23, 2025
pulisher
Feb 23, 2025

Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

How to Take Advantage of moves in (CYBN) - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 20, 2025

Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor

Feb 20, 2025
pulisher
Feb 18, 2025

Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Cybin stock price target cut to $150 at H.C. Wainwright - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

(CYBN) Investment Analysis - Stock Traders Daily

Feb 12, 2025
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):